1379 |
Concept of Polymerase Chain Reaction [PCR] Amplification of the Target |
28/07/2023 |
Laboratory services and management |
4496 |
Concept of NIKSHAY Episode, Case in the care cascade |
28/07/2023 |
Ni-kshay, Information Systems and DBT |
5331 |
Conducting Supportive Supervision Visits |
28/07/2023 |
Surveillance, SM&E and Epidemiology |
1823 |
Constituents of Monthly Patient-wise Boxes [PWB] for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen |
28/07/2023 |
DR-TB and PMDT |
1013 |
Constituents of Patient-wise Boxes [PWB] for Isoniazid [H] Mono/Poly DR-TB Regimen |
28/07/2023 |
DR-TB and PMDT |
1748 |
Consumables Required at a Truenat Lab |
28/07/2023 |
Laboratory services and management |
1941 |
Contamination Control During DNA Extraction in LPA Lab Settings |
31/07/2023 |
Laboratory services and management |
1943 |
Contamination Control During PCR Reagent Preparation in the LPA Lab |
31/07/2023 |
Laboratory services and management |
1945 |
Contamination Control in the Amplification Room in the LPA Lab |
31/07/2023 |
Laboratory services and management |
1267 |
Contamination Control in the Hybridization Area in LPA Lab Settings |
31/07/2023 |
Laboratory services and management |
5321 |
Contract extensions |
31/07/2023 |
Policy and planning, NTEP PIP, Admin related matters |
4500 |
Costing norms in NTEP |
31/07/2023 |
Accounting Finance and Admin |
264 |
COVID-19 in TB patients |
31/07/2023 |
TB Comorbidities and special conditions |
1246 |
Culture Specimen Processing: Advantages and Disadvantages of NALC-NaOH Method |
31/07/2023 |
Laboratory services and management |
1240 |
Culturing of Mycobacteria: Labelling of Reagents |
31/07/2023 |
Laboratory services and management |
1239 |
Culturing of Mycobacteria: Process of Preparation of 0.067M Phosphate Buffer |
31/07/2023 |
Laboratory services and management |
1366 |
Daily Maintenance of the CBNAAT Instrument |
31/07/2023 |
Laboratory services and management |
1372 |
Daily, Weekly and Monthly Maintenance of Truenat Instrument |
31/07/2023 |
Laboratory services and management |
3880 |
Decontamination of Contaminated MGIT Culture |
03/10/2023 |
Laboratory services and management |
3342 |
Deduplication Register |
03/10/2023 |
Ni-kshay, Information Systems and DBT |
1025 |
Delamanid [Dlm] Drug Dosages and Duration |
03/10/2023 |
DR-TB and PMDT |
3334 |
Deleted Patient Register |
03/10/2023 |
Ni-kshay, Information Systems and DBT |
947 |
Designing effective messages |
03/10/2023 |
Advocacy communication and social mobilization |
1868 |
Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen |
03/10/2023 |
DR-TB and PMDT |
944 |
Developing ACSM objectives |
03/10/2023 |
Advocacy communication and social mobilization |
1850 |
Difficult-to-Treat TB Clinic [DT3C] |
03/10/2023 |
DR-TB and PMDT |
2364 |
Direct Procurement through GeM |
03/10/2023 |
Procurement and supply chain management |
218 |
Dispatching the sample to a C&DST Lab |
03/10/2023 |
Laboratory services and management |
1316 |
Disposal of Infectious Samples and Used Cartridges in CBNAAT Lab |
03/10/2023 |
Laboratory services and management |
1300 |
Disposal of Infectious Samples and Used Cartridges in TrueNAT Laboratories |
03/10/2023 |
Laboratory services and management |